MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Charts
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
TTI stock logo

TTI

TETRA Technologies, Inc.

$9.02
0.15
 (1.69%)
Exchange:  NYSE
Market Cap:  1.319B
Shares Outstanding:  44.954M
Delayed data
Calculate TTI Intrinsic Value
5-year outlook →
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Energy
Industry:  Oil & Gas Equipment & Services
   
CEO:  Brady Murphy
Full Time Employees:  1400
Address: 
10000 Energy Drive
Spring
TX
77380
US
Website:  https://www.tetratec.com
TETRA Technologies, Inc. (TTI) is a diversified enterprise that delivers a range of services to the oil and gas industry. The company organizes its operations into two primary divisions: Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products segment is responsible for the production and distribution of specialized chemical formulations, such as clear brine fluids, various additives, and complementary services. These products are vital for well drilling, completion, and workover procedures in the oil and gas sector, with a market presence spanning the United States, Latin America, Europe, Asia, the Middle East, and Africa. This division also trades in both liquid and dry calcium chloride products. The Water & Flowback Services segment offers comprehensive water management solutions designed for onshore oil and gas operators. Additionally, it provides services like frac flowback and production well testing, along with other related support. These services are delivered across oil and gas producing areas in the United States and Mexico, as well as in numerous basins throughout Latin America, Africa, Europe, and the Middle East. Founded in 1981, TETRA Technologies, Inc. is headquartered in The Woodlands, Texas.

Click to read more…

Revenue Segmentation

MARKETSnap
MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/04/30 — Q1 quarter 2026

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue626,262599,111630,932
Gross Profit141,642139,962160,111
EBITDA88,37786,92880,928
Operating Income45,55449,99359,552
Net Income25,784108,2843,005

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets499,523718,5830
Total Liabilities352,189465,276236,811
Total Stockholders Equity148,591254,568283,755
Total Debt196,800221,39143,990
Cash and Cash Equivalents52,48537,2080

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow70,20636,520100,360
Capital Expenditure-38,152-60,680-80,821
Free Cash Flow32,054-24,16019,539
Net Income25,506108,2804,207
Net Change in Cash38,893-15,27735,472

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2028Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Low)821,500Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (High)830,499.999Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Avg)826,000Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Low)149,447.749Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (High)151,085.034Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Avg)150,266.391Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Low)54,228.937Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (High)90,381.563Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Avg)79,050Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Low)135,263.462Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (High)136,745.350Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Avg)136,004.406Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Avg)0.540Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (High)0.670Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Low)0.400Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated Revenue)2Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated EPS)2Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
599.111M  ?P/S
 (TTM)
: 
2.15
?Net Income
 (TTM)
: 
108.284M  ?P/E
 (TTM)
: 
136.38
?Enterprise Value
 (TTM)
: 
1.543B  ?EV/FCF
 (TTM)
: 
574.54
?Dividend Yield
 (TTM)
: 
0%  ?Payout Ratio
 (TTM)
: 
0%
?ROE
 (TTM)
: 
2.51%  ?ROIC
 (TTM)
: 
2.55%
?Net Debt
 (TTM)
: 
184.183M  ?Debt/Equity
 (TTM)
: 
0.78
?P/B
 (TTM)
: 
4.34  ?Current Ratio
 (TTM)
: 
2.02

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
33.41Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.

[intrinsic_calculator]

Common questions about TTI valuation

Is TETRA Technologies, Inc. (TTI) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for TETRA Technologies, Inc. (TTI) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is TTI a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether TTI trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is TTI’s P/E ratio?

You can see TTI’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for TTI?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is TTI a good long-term investment?

Whether TTI fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

TTI

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

1.69
MARKETSnap

Trading Metrics:

Open: 8.97   Previous Close: 8.87
Day Low: 8.89   Day High: 9.05
Year Low: 3.37   Year High: 12.54
Price Avg 50: 10.07   Price Avg 200: 9.17
Volume: 78553   Average Volume: 1.661M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

TETRA TECHNOLOGIES, INC. ANNOUNCES DATE FOR SECOND QUARTER 2026 EARNINGS CONFERENCE CALL
13-07-2026 16:00
TETRA TECHNOLOGIES, INC. ANNOUNCES DATE FOR SECOND QUARTER 2026 EARNINGS CONFERENCE CALL
Thiogenesis Receives FDA Rare Pediatric Disease Designation for TTI-0102 for the Treatment of Leigh Syndrome
13-07-2026 06:00
Thiogenesis Receives FDA Rare Pediatric Disease Designation for TTI-0102 for the Treatment of Leigh Syndrome
Tvardi Therapeutics, Inc. (TVRD) Discusses Phase 1 Data on TTI-109 STAT3 Inhibitor Highlighting Prodrug Design, Tolerability and Target Engagement Transcript
07-07-2026 18:02
Tvardi Therapeutics, Inc. (TVRD) Discusses Phase 1 Data on TTI-109 STAT3 Inhibitor Highlighting Prodrug Design, Tolerability and Target Engagement Transcript
TETRA Technologies, Inc. (TTI) Presents at J.P. Morgan Natural Resources Conference 2026 Transcript
24-06-2026 13:32
TETRA Technologies, Inc. (TTI) Presents at J.P. Morgan Natural Resources Conference 2026 Transcript
Can Viavi's New TETRA Testing Upgrade Strengthen Its Growth Story?
16-06-2026 10:26
Can Viavi's New TETRA Testing Upgrade Strengthen Its Growth Story?
VIAVI Launches TETRA MS Base Station Simulator Option for CX300 to Simplify and Speed Mission-Critical Radio Testing
15-06-2026 06:30
VIAVI Launches TETRA MS Base Station Simulator Option for CX300 to Simplify and Speed Mission-Critical Radio Testing

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlist & Portfolio Watchlist & Portfolio
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read